Los Angeles Capital Management’s Usana Health Sciences USNA Stock Holding History

Los Angeles Capital Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.86K	Hold	87	–	–	﹤0.01%	2262
2026 Q1	$1.52K	Hold	87	–	–	﹤0.01%	2315
2025 Q4	$1.72K	Buy	+87	New	+$1.8K	﹤0.01%	2450
2025 Q3	–	Sell	-11,972	Closed	-$366K	–	1545
2025 Q2	$366K	Buy	+11,972	New	+$340K	﹤0.01%	983
2023 Q4	–	Sell	-26,651	Closed	-$1.56M	–	1242
2023 Q3	$1.56M	Sell	26,651 -11,701	-31%	-$732K	0.01%	510
2023 Q2	$2.42M	Buy	38,352 +32,859	+598%	+$2.09M	0.01%	447
2023 Q1	$346K	Sell	5,493 -600	-10%	-$35.8K	﹤0.01%	966
2022 Q4	$324K	Sell	6,093 -313	-5%	-$17K	﹤0.01%	1015
2022 Q3	$359K	Sell	6,406 -2,085	-25%	-$138K	﹤0.01%	1025
2022 Q2	$614K	Sell	8,491 -914	-10%	-$68.1K	﹤0.01%	890
2022 Q1	$747K	Sell	9,405 -118	-1%	-$10.6K	﹤0.01%	878
2021 Q4	$964K	Sell	9,523 -14,321	-60%	-$1.43M	﹤0.01%	736
2021 Q3	$2.2M	Sell	23,844 -1,280	-5%	-$123K	0.01%	510
2021 Q2	$2.57M	Sell	25,124 -15,260	-38%	-$1.53M	0.01%	533
2021 Q1	$3.94M	Sell	40,384 -4,348	-10%	-$396K	0.02%	457
2020 Q4	$3.45M	Sell	44,732 -291	-0.6%	-$22.5K	0.01%	489
2020 Q3	$3.32M	Buy	45,023 +2,645	+6%	+$212K	0.02%	424
2020 Q2	$3.11M	Buy	42,378 +34,090	+411%	+$2.67M	0.02%	503
2020 Q1	$479K	Buy	+8,288	New	+$576K	﹤0.01%	920
2019 Q3	–	Sell	-7,816	Closed	-$621K	–	1372
2019 Q2	$621K	Sell	7,816 -1,770	-18%	-$140K	﹤0.01%	981
2019 Q1	$804K	Sell	9,586 -9,690	-50%	-$1.01M	﹤0.01%	932
2018 Q4	$2.27M	Buy	19,276 +6,512	+51%	+$753K	0.01%	522
2018 Q3	$1.54M	Buy	+12,764	New	+$1.58M	0.01%	738

Other funds holding USNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Los Angeles Capital Management's USNA Position: Q2 2026 in Review

Los Angeles Capital Management held its Usana Health Sciences (USNA) position steady in Q2 2026 at 87 shares worth $1.86K. The position accounts for ﹤0.01% of the portfolio, ranked #2262.

Los Angeles Capital Management first reported a position in USNA in Q3 2018 and has held it in 23 quarters since. The position peaked at $3.94M in Q1 2021. 138 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

Los Angeles Capital Management held 87 shares of Usana Health Sciences worth $1.86K as of Q2 2026.
Los Angeles Capital Management left its Usana Health Sciences share count unchanged in Q2 2026.
Usana Health Sciences made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #2262 holding.
Los Angeles Capital Management first reported a position in Usana Health Sciences in Q3 2018 and has held it in 23 quarters since.
Los Angeles Capital Management's Usana Health Sciences position peaked at $3.94M in Q1 2021.
138 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.